Paul Shattock

1.2k total citations
26 papers, 869 citations indexed

About

Paul Shattock is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Paul Shattock has authored 26 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cognitive Neuroscience, 15 papers in Psychiatry and Mental health and 8 papers in Genetics. Recurrent topics in Paul Shattock's work include Autism Spectrum Disorder Research (16 papers), Child Nutrition and Feeding Issues (11 papers) and Genetics and Neurodevelopmental Disorders (8 papers). Paul Shattock is often cited by papers focused on Autism Spectrum Disorder Research (16 papers), Child Nutrition and Feeding Issues (11 papers) and Genetics and Neurodevelopmental Disorders (8 papers). Paul Shattock collaborates with scholars based in United Kingdom, United States and Norway. Paul Shattock's co-authors include Paul Whiteley, Dawn Savery, Ann‐Mari Knivsberg, Karl L. Reichelt, Anders Seim, Jacqui Rodgers, Lennart Pedersen, Kevin Carr, Alan Kennedy and Thomas P. Berney and has published in prestigious journals such as The British Journal of Psychiatry, Developmental Medicine & Child Neurology and Frontiers in Human Neuroscience.

In The Last Decade

Paul Shattock

24 papers receiving 787 citations

Peers

Countries citing papers authored by Paul Shattock

Since Specialization

Citations

This map shows the geographic impact of Paul Shattock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Shattock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Shattock more than expected).

Fields of papers citing papers by Paul Shattock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Shattock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Shattock. The network helps show where Paul Shattock may publish in the future.

Co-authorship network of co-authors of Paul Shattock

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Shattock. A scholar is included among the top collaborators of Paul Shattock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Shattock. Paul Shattock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From autism to the plural ‘autisms’: evidence from differing aetiologies, developmental trajectories and symptom intensity combinations 2025 ·The British Journal of Psychiatry ·(unknown), Kevin Carr, Paul Shattock, (unknown), Carol Stott, Kristina K. Hardy, (unknown)	0
2	Research, Clinical, and Sociological Aspects of Autism 2021 ·Frontiers in Psychiatry ·Paul Whiteley, Kevin Carr, Paul Shattock	11
3	<p>Bridging the Gap Between Physical Health and Autism Spectrum Disorder</p> 2020 ·Neuropsychiatric Disease and Treatment ·Regina Sala, (unknown), (unknown), Paul Shattock, Paul Whiteley	26
4	<p>Is Autism Inborn And Lifelong For Everyone?</p> 2019 ·Neuropsychiatric Disease and Treatment ·Paul Whiteley, Kevin Carr, Paul Shattock	20
5	Ex vivostudies for the passive transdermal delivery of low-dose naltrexone from a cream; detection of naltrexone and its active metabolite, 6β-naltrexol, using a novel LC Q-ToF MS assay 2014 ·Pharmaceutical Development and Technology ·Kalliopi Dodou, (unknown), (unknown), Simon Wilkinson, Kevin Carr, Paul Shattock, Paul Whiteley	6
6	Gluten- and casein-free dietary intervention for autism spectrum conditions 2013 ·Frontiers in Human Neuroscience ·Paul Whiteley, Paul Shattock, Ann‐Mari Knivsberg, Anders Seim, Karl L. Reichelt, (unknown), Kevin Carr, (unknown)	81
7	Data mining the ScanBrit study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders: Behavioural and psychometric measures of dietary response 2013 ·Nutritional Neuroscience ·Lennart Pedersen, (unknown), Kajsa Kvist, Paul Whiteley, Paul Shattock	34
8	The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders 2010 ·Nutritional Neuroscience ·Paul Whiteley, (unknown), Ann‐Mari Knivsberg, Karl L. Reichelt, (unknown), (unknown), Anders Seim, Lennart Pedersen, (unknown), Paul Shattock	195
9	How Could a Gluten- and Casein-Free Diet Ameliorate Symptoms Associated with Autism Spectrum Conditions? 2010 ·Paul Whiteley, Paul Shattock, Kevin Carr, (unknown), (unknown)	8
10	Development and reproducibility of a novel high‐performance liquid‐chromatography monolithic column method for the detection and quantification of trans‐indolyl‐3‐acryloylglycine in human urine 2009 ·Biomedical Chromatography ·Kevin Carr, Paul Whiteley, Paul Shattock	7
11	Trends in Developmental, Behavioral and somatic Factors by Diagnostic sub-group in pervasive Developmental Disorders: A Follow-up Analysis 2009 ·(unknown), (unknown), Kalliopi Dodou, Paul Shattock	2
12	Spot urinary creatinine excretion in pervasive developmental disorders 2006 ·Pediatrics International ·Paul Whiteley, R. H. Waring, (unknown), (unknown), (unknown), Susan Smith, Malcolm Farrow, Kalliopi Dodou, (unknown), Paul Shattock	25
13	Body mass index of children from the United Kingdom diagnosed with pervasive developmental disorders 2004 ·Pediatrics International ·Paul Whiteley, Kalliopi Dodou, (unknown), Paul Shattock	37
14	Urinary compounds in autism 2004 ·Journal of Intellectual Disability Research ·Alyssa M. Alcorn, T. P. Berney, (unknown), (unknown), Dawn Savery, Paul Shattock	9
15	Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention 2002 ·Expert Opinion on Therapeutic Targets ·Paul Whiteley, Paul Shattock	98
16	Identification of indolyl-3-acryloylglycine in the urine of people with autism 2002 ·Journal of Pharmacy and Pharmacology ·Rosaleen J. Anderson, David Bendell, (unknown), Paul W. Groundwater, W. John Lough, (unknown), Dawn Savery, Paul Shattock	19
17	MMR and Autism: C. Gillberg & H. Heijdal, Autism, 1998, 2(4), 423-4 1999 ·Autism ·Paul Shattock, Paul Whiteley	2
18	A Gluten-Free Diet as an Intervention for Autism and Associated Spectrum Disorders: Preliminary Findings 1999 ·Autism ·Paul Whiteley, Jacqui Rodgers, Dawn Savery, Paul Shattock	97
19	Rapid analysis of low levels of indolyl-3-acryloylglycine in human urine by high-performance liquid chromatography 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), Dawn Savery, Paul Shattock	17
20	Role of neuropeptides in autism and their relationships with classical neurotransmitters 1990 ·Paul Shattock, Alan Kennedy, (unknown), Thomas P. Berney	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact